(Q37356684)

19 August 2017

1 reference

title

Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? (English)

1 reference

19 August 2017

1 reference

Felipe Correa Geyer

1

1 reference

PubMed ID

19103611

19 August 2017

Jorge Sergio Reis-Filho

series ordinal

2

1 reference

19 August 2017

22 December 2008

1 reference

International Journal of Surgical Pathology

19 August 2017

1 reference

19 August 2017

17

1 reference

19 August 2017

4

1 reference

19 August 2017

285-302

1 reference

The molecular genetics of breast cancer: the contribution of comparative genomic hybridization

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Molecular evolution of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Trastuzumab: triumphs and tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Determination of stromal signatures in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Evaluation of biological pathways involved in chemotherapy response in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Interpretation of microarray data in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The impact of expression profiling on prognostic and predictive testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Nestin is expressed in basal-like and triple negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A mouse model of basal-like breast carcinoma with metaplastic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Are triple-negative tumours and basal-like breast cancer synonymous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

How basal are triple-negative breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Basal-like breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Impact of basal-like breast carcinoma determination for a more specific therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Clinical application of the 70-gene profile: the MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Roadmap for developing and validating therapeutically relevant genomic classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

RNA expression analysis of formalin-fixed paraffin-embedded tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Histopathologic variables predict Oncotype DX recurrence score

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Commercialized multigene predictors of clinical outcome for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiles of human breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Histological grading of breast carcinomas: a study of interobserver agreement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Proliferation: the most prominent predictor of clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Limits of predictive models using microarray data for breast cancer clinical treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Prediction of docetaxel response in human breast cancer by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Molecular characterization of the tumor microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The fibromatosis signature defines a robust stromal response in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Regulation of in situ to invasive breast carcinoma transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Unraveling the microenvironmental influences on the normal mammary gland and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Comparison of prognostic gene expression signatures for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

What would you do if you could sequence everything?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The beginning of the end for microarrays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

The death of microarrays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896908328577

21 January 2018

Identifiers

DOI

10.1177/1066896908328577

1 reference

19 August 2017

1 reference

PubMed ID

19103611